NCT00062777View on ClinicalTrials.gov

The Framingham Study: Examining DNA Markers and Links to Diseases

CompletedOBSERVATIONAL
Enrollment

330

Participants

Timeline

Start Date

June 12, 2003

Study Completion Date

June 16, 2011

Conditions
Vascular Diseases
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00062777 - The Framingham Study: Examining DNA Markers and Links to Diseases | Biotech Hunter | Biotech Hunter